» Articles » PMID: 11595513

Non-toxic Ubiquitous Over-expression of Utrophin in the Mdx Mouse

Overview
Specialty Neurology
Date 2001 Oct 12
PMID 11595513
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Duchenne muscular dystrophy (DMD) is an inherited, severe muscle wasting disease caused by the loss of the cytoskeletal protein, dystrophin. Patients usually die in their late teens or early twenties of cardiac or respiratory failure. We have previously demonstrated that the dystrophin related protein, utrophin is able to compensate for the loss of dystrophin in the mdx mouse, the mouse model of the disease. Expression of a utrophin transgene under the control of an HSA promoter results in localization of utrophin to the sarcolemma and prevents the muscle pathology. Here we show that the over-expression of full-length utrophin in a broad range of tissues is not detrimental in the mdx mouse. These findings have important implications for the feasibility of the up-regulation of utrophin in therapy for DMD since they suggest that tissue specific up-regulation may not be necessary.

Citing Articles

Molecular pathways involved in the control of contractile and metabolic properties of skeletal muscle fibers as potential therapeutic targets for Duchenne muscular dystrophy.

Bonato A, Raparelli G, Caruso M Front Physiol. 2024; 15:1496870.

PMID: 39717824 PMC: 11663947. DOI: 10.3389/fphys.2024.1496870.


CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments.

Laurent M, Geoffroy M, Pavani G, Guiraud S Cells. 2024; 13(10.

PMID: 38786024 PMC: 11119143. DOI: 10.3390/cells13100800.


Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review.

Szwec S, Kaplucha Z, Chamberlain J, Konieczny P BioDrugs. 2023; 38(1):95-119.

PMID: 37917377 PMC: 10789850. DOI: 10.1007/s40259-023-00632-3.


Therapeutic approaches for Duchenne muscular dystrophy.

Roberts T, Wood M, Davies K Nat Rev Drug Discov. 2023; 22(11):917-934.

PMID: 37652974 DOI: 10.1038/s41573-023-00775-6.


Endogenous bioluminescent reporters reveal a sustained increase in utrophin gene expression upon EZH2 and ERK1/2 inhibition.

Gleneadie H, Fernandez-Ruiz B, Sardini A, Van de Pette M, Dimond A, Prinjha R Commun Biol. 2023; 6(1):318.

PMID: 36966198 PMC: 10039851. DOI: 10.1038/s42003-023-04666-9.